Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
EXEL > SEC Filings for EXEL > Form 8-K on 23-May-2013All Recent SEC Filings

Show all filings for EXELIXIS, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for EXELIXIS, INC.


23-May-2013

Submission of Matters to a Vote of Security Holders


Item 5.07. Submission of Matters to a Vote of Security Holders.

Exelixis, Inc. held its Annual Meeting of Stockholders (the "Annual Meeting") on May 22, 2013, at its offices located at 210 East Grand Avenue, South San Francisco, CA 94080. At the Annual Meeting, Exelixis stockholders were asked to vote upon:

1. The election of three Class II directors for a three-year term until the 2016 annual meeting of stockholders. The nominees for election to these positions were Carl B. Feldbaum, Esq., Alan M. Garber, M.D., Ph.D. and Vincent T. Marchesi, M.D., Ph.D.;

2. The ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Exelixis' independent registered public accounting firm for the fiscal year ending December 27, 2013; and

3. The approval, on an advisory basis, of the compensation of Exelixis' named executive officers, as disclosed in Exelixis' Proxy Statement for the Annual Meeting.

The voting results of the matters presented at the Annual Meeting are as follows:

1. The election of each of Mr. Feldbaum and Drs. Garber and Marchesi, as directors of Exelixis until the 2016 annual meeting of stockholders, and until his successor is elected and qualified, or until his earlier death, resignation or removal, was approved as follows:

                                      FOR        AGAINST     ABSTAIN    BROKER NON-VOTES
Carl B. Feldbaum, Esq.             99,797,922    961,644    3,114,570      53,776,805
Alan M. Garber, M.D., Ph.D.        99,952,857    818,905    3,102,371      53,776,805
Vincent T. Marchesi, M.D., Ph.D.   99,532,431   1,235,074   3,106,628      53,776,805

Exelixis' Class III directors, Frank McCormick, Ph.D., FRS, Michael M. Morrissey, Ph.D., Stelios Papadopoulos, Ph.D., George A. Scangos, Ph.D. and Lance Willsey, M.D., will each continue to serve on the Board of Directors until the 2014 annual meeting of stockholders and until his successor is elected and qualified, or until his earlier death, resignation or removal. Exelixis' Class I directors, Charles Cohen, Ph.D., George Poste, D.V.M., Ph.D., FRS, and Jack L. Wyszomierski, will each continue to serve on the Board of Directors until the 2015 annual meeting of stockholders and until his successor is elected and qualified, or until his earlier death, resignation or removal.

2. The ratification of Ernst & Young LLP as Exelixis' independent registered public accounting firm for the fiscal year ending December 27, 2013, was approved as follows:

FOR AGAINST ABSTAIN BROKER NON-VOTES
151,288,786 2,061,378 4,300,774 0

3. The compensation of Exelixis' named executive officers, as disclosed in Exelixis' Proxy Statement for the Annual Meeting, received advisory approval as follows:

FOR AGAINST ABSTAIN BROKER NON-VOTES
98,633,118 2,034,496 3,206,519 53,776,805

  Add EXEL to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for EXEL - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.